Synthego vs Cellares

Synthego was a Redwood City CRISPR-tools company supplying synthetic guide RNA and engineered cells plus the Eclipse automation platform; it filed Chapter 11 in May 2025 and was sold to creditor Perceptive Advisors.

Biotech

Cellares

Automated 'Cell Shuttle' factories that industrialize and scale cell-therapy manufacturing.

For subscribers

Subscribe for the full comparison

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →